Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rebecca Marnocha
Observed names:
R Marnocha,
R. M. Marnocha,
R. Marnocha,
Rebecca M. Marnocha,
Rebecca Marnoccha,
Rebecca S. Mutch Marnocha
show all 6
Institution:
University of Wisconsin–Madison
Observed institutions:
National Institutes of Health,
University of Wisconsin System,
University of Wisconsin–Madison,
UW Health University Hospital,
University of Wisconsin Carbone Cancer Center,
National Cancer Institute,
The Ohio State University
show all 7
OpenAlex ID:
A5111859149
Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer
2009
·
Douglas G. McNeel
, Edward J. Dunphy
, et al.
·
Journal of Clinical Oncology
·
248
PDF
Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors
2003
·
James P. Thomas
, Rhoda Z. Arzoomanian
, et al.
·
Journal of Clinical Oncology
·
223
A Phase I Trial of Perifosine (NSC 639966) on a Loading Dose/Maintenance Dose Schedule in Patients with Advanced Cancer
2004
·
Lynn Van Ummersen
, Kim Binger
, et al.
·
Clinical Cancer Research
·
158
Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion
2005
·
Douglas G. McNeel
, Jens Eickhoff
, et al.
·
Clinical Cancer Research
·
156
Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol
2002
·
James P. Thomas
, Kendra D. Tutsch
, et al.
·
Cancer Chemotherapy and Pharmacology
·
123
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.
2000
·
G H Ripple
, M N Gould
, et al.
·
PubMed
·
106
A Phase I and Pharmacologic Trial of Two Schedules of the Proteasome Inhibitor, PS-341 (Bortezomib, Velcade), in Patients with Advanced Cancer
2005
·
Grace K. Dy
, James P. Thomas
, et al.
·
Clinical Cancer Research
·
65
PDF
Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.
2002
·
Glenn Liu
, Kurt Oettel
, et al.
·
PubMed
·
65
Pharmacodynamic Study Using FLT PET/CT in Patients with Renal Cell Cancer and Other Solid Malignancies Treated with Sunitinib Malate
2011
·
Glenn Liu
, Robert Jeraj
, et al.
·
Clinical Cancer Research
·
64
Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer
2008
·
Steven Attia
, Jens Eickhoff
, et al.
·
Clinical Cancer Research
·
61
PDF
A survey of practices for the use of electronic health records to support research recruitment
2017
·
Jihad S. Obeid
, Laura M. Beskow
, et al.
·
Journal of Clinical and Translational Science
·
55
PDF
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer
2013
·
William R. Schelman
, Tabraiz A. Mohammed
, et al.
·
Investigational New Drugs
·
47
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors
2013
·
Dustin A. Deming
, Jacob Ninan
, et al.
·
Investigational New Drugs
·
44
A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
2008
·
William R. Schelman
, Sherry Morgan-Meadows
, et al.
·
Cancer Chemotherapy and Pharmacology
·
34
A phase I trial of perillyl alcohol administered four times daily for 14�days out of 28�days
2004
·
HowardH. Bailey
, George Wilding
, et al.
·
Cancer Chemotherapy and Pharmacology
·
32
A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors
1998
·
Jordan D. Berlin
, Dona B. Alberti
, et al.
·
Investigational New Drugs
·
32
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies
2013
·
William R. Schelman
, Anne M. Traynor
, et al.
·
Investigational New Drugs
·
28
Phase I trial of perillyl alcohol administered four times daily continuously
2003
·
Sherry Morgan-Meadows
, Sarita Dubey
, et al.
·
Cancer Chemotherapy and Pharmacology
·
27
Intradermal carboplatin and ifosfamide extravasation in the mouse
1992
·
Rebecca S. Mutch Marnocha
, Paul R. Hutson
·
Cancer
·
23
PDF
A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer
2008
·
Noelle K. LoConte
, James P. Thomas
, et al.
·
Cancer Chemotherapy and Pharmacology
·
22
Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats.
2002
·
Joseph Merchant
, Kendra Tutsch
, et al.
·
PubMed
·
20
A Phase I Pharmacokinetic and Pharmacodynamic Correlative Study of the Antisense Bcl-2 Oligonucleotide G3139, in Combination with Carboplatin and Paclitaxel, in Patients with Advanced Solid Tumors
2008
·
Glenn Liu
, Jill Kolesar
, et al.
·
Clinical Cancer Research
·
19
The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors
2010
·
Brian S. Choi
, Dona B. Alberti
, et al.
·
Cancer Chemotherapy and Pharmacology
·
18
Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of food.
2002
·
Jordan Berlin
, Kendra D Tutsch
, et al.
·
PubMed
·
18
A phase I study of vorinostat in combination with bortezomib in refractory solid tumors
2009
·
J. A. Ninan
, H. Bailey
, et al.
·
Journal of Clinical Oncology
·
17
Show more works
View as search
Works count:
45
Citation count:
1,792
H-index:
20
I10-index:
28
Year
Topic
Type
